Compare Stocks: PGNY, HIMS, CHE, and RDNT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CHE Chemed	$499.14 +0.2%	$521.28	$365.20 ▼ $557.00	$6.51B	0.51	164,772 shs	134,463 shs
HIMS Hims & Hers Health	$30.87 +10.0%	$29.45	$13.74 ▼ $65.30	$6.55B	2.44	9.85 million shs	15.98 million shs
PGNY Progyny	$27.93 +0.4%	$26.70	$16.10 ▼ $33.06	$2.14B	1.02	1.27 million shs	694,542 shs
RDNT RadNet	$70.91 +4.0%	$73.37	$50.82 ▼ $85.84	$5.37B	1.41	758,213 shs	507,437 shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CHE Chemed	-0.03%	-1.87%	-3.66%	+2.33%	+14.80%
HIMS Hims & Hers Health	+10.03%	+6.57%	+11.00%	-10.40%	-46.89%
PGNY Progyny	+0.36%	+10.70%	+2.99%	-8.87%	+35.71%
RDNT RadNet	+3.96%	+1.40%	+0.06%	+8.09%	-6.80%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CHE Chemed	$499.14 +0.2%	$521.28	$365.20 ▼ $557.00	$6.51B	0.51	164,772 shs	134,463 shs
HIMS Hims & Hers Health	$30.87 +10.0%	$29.45	$13.74 ▼ $65.30	$6.55B	2.44	9.85 million shs	15.98 million shs
PGNY Progyny	$27.93 +0.4%	$26.70	$16.10 ▼ $33.06	$2.14B	1.02	1.27 million shs	694,542 shs
RDNT RadNet	$70.91 +4.0%	$73.37	$50.82 ▼ $85.84	$5.37B	1.41	758,213 shs	507,437 shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CHE Chemed	-0.03%	-1.87%	-3.66%	+2.33%	+14.80%
HIMS Hims & Hers Health	+10.03%	+6.57%	+11.00%	-10.40%	-46.89%
PGNY Progyny	+0.36%	+10.70%	+2.99%	-8.87%	+35.71%
RDNT RadNet	+3.96%	+1.40%	+0.06%	+8.09%	-6.80%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CHE Chemed	2.29	Hold	$554.60	11.11% Upside
HIMS Hims & Hers Health	2.13	Hold	$32.43	5.08% Upside
PGNY Progyny	2.85	Moderate Buy	$34.36	23.03% Upside
RDNT RadNet	2.89	Moderate Buy	$90.00	26.92% Upside

Current Analyst Ratings Breakdown

Latest PGNY, HIMS, CHE, and RDNT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/8/2026	CHE Chemed	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)
10/8/2026	PGNY Progyny	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)
9/30/2026	PGNY Progyny	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$37.00
9/25/2026	CHE Chemed	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$650.00
9/25/2026	CHE Chemed	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$650.00
9/25/2026	CHE Chemed	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$650.00
9/22/2026	RDNT RadNet	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Strong-Buy
9/11/2026	HIMS Hims & Hers Health	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$32.00
9/8/2026	PGNY Progyny	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
9/8/2026	PGNY Progyny	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$33.00
9/8/2026	PGNY Progyny	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Market Outperform	$31.00 ➝ $33.00

(Data available from 10/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CHE Chemed	$2.53B	2.58	$24.71 per share	20.20	$69.15 per share	7.22
HIMS Hims & Hers Health	$2.35B	3.07	$0.92 per share	33.53	$2.38 per share	12.97
PGNY Progyny	$1.29B	1.66	$0.74 per share	37.80	$5.99 per share	4.66
RDNT RadNet	$2.27B	2.46	$3.35 per share	21.16	$17.58 per share	4.03

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CHE Chemed	$265.24M	$19.91	25.07	19.83	2.00	10.60%	31.77%	18.90%	10/27/2026 (Estimated)
HIMS Hims & Hers Health	$128.37M	-$0.63	N/A	70.15	N/A	-5.51%	-6.51%	-1.20%	11/9/2026 (Estimated)
PGNY Progyny	$58.52M	$0.92	30.36	19.67	1.92	6.00%	15.98%	10.65%	11/5/2026 (Estimated)
RDNT RadNet	-$18.65M	-$0.27	N/A	81.51	N/A	-0.93%	2.61%	0.91%	11/9/2026 (Estimated)

Latest PGNY, HIMS, CHE, and RDNT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/5/2026	Q3 2026	PGNY Progyny	$0.3130	N/A	N/A	N/A	$340.62 million	N/A
10/27/2026	Q3 2026	CHE Chemed	$6.39	N/A	N/A	N/A	$685.04 million	N/A
8/10/2026	Q2 2026	HIMS Hims & Hers Health	-$0.0498	-$0.37	-$0.3202	-$0.37	$698.90 million	$753.21 million
8/10/2026	Q2 2026	RDNT RadNet	$0.2014	$0.29	+$0.0886	$0.10	$610.87 million	$622.72 million
8/6/2026	Q2 2026	PGNY Progyny	$0.3348	$0.55	+$0.2152	$0.34	$349.05 million	$350.51 million
7/28/2026	Q2 2026	CHE Chemed	$5.60	$6.06	+$0.46	$5.13	$665.04 million	$673.25 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CHE Chemed	$2.80	0.56%	+10.76%	14.06%	16 Years
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
PGNY Progyny	N/A	N/A	N/A	N/A	N/A
RDNT RadNet	N/A	N/A	N/A	N/A	N/A

Latest PGNY, HIMS, CHE, and RDNT Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/6/2026	CHE Chemed	quarterly	$0.70	0.53%	8/17/2026	8/17/2026	9/3/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CHE Chemed	0.17	0.91	0.89
HIMS Hims & Hers Health	4.21	0.93	0.87
PGNY Progyny	N/A	2.14	2.14
RDNT RadNet	0.94	1.48	1.48

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CHE Chemed	95.85%
HIMS Hims & Hers Health	63.52%
PGNY Progyny	94.93%
RDNT RadNet	77.90%

Insider Ownership

Company	Insider Ownership
CHE Chemed	3.33%
HIMS Hims & Hers Health	11.76%
PGNY Progyny	9.90%
RDNT RadNet	5.14%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CHE Chemed	15,811	13.07 million	12.64 million	Optionable
HIMS Hims & Hers Health	2,442	233.31 million	205.88 million	Optionable
PGNY Progyny	856	76.73 million	69.13 million	Optionable
RDNT RadNet	11,264	78.70 million	74.65 million	Optionable

PGNY, HIMS, CHE, and RDNT Headlines

Recent News About These Companies

Q2 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Earns Top Marks

October 8 at 11:53 PM | finance.yahoo.com

New Study Shows DeepHealth AI Could Help Avoid Nearly One in Five Prostate Biopsies

October 8 at 6:00 AM | globenewswire.com

RadNet stock gained 3.29 percent as revenue rose 25.0 percent

October 5, 2026 | ad-hoc-news.deA

RadNet, Inc. (NASDAQ:RDNT) Stock Now Rated "Moderate Buy" by Wall Street Brokerages

October 3, 2026 | americanbankingnews.com

RadNet, Inc. (NASDAQ:RDNT) Stock Has Consensus Target Price of $90.00

October 3, 2026 | marketbeat.com

RadNet (NASDAQ:RDNT) Share Price Crosses Above 200-Day Moving Average - Time to Sell?

October 2, 2026 | americanbankingnews.com

RadNet (NASDAQ:RDNT) Stock Crosses Above 200 Day Moving Average - Should You Sell?

October 2, 2026 | marketbeat.com

Raymond James starts RadNet coverage with Strong Buy for RadNet stock

October 2, 2026 | ad-hoc-news.deA

RadNet Teams Up With WIN-NextGen To Inspire Future Medical Imaging Professionals

October 1, 2026 | rttnews.com

RadNet and WIN-NextGen™ Form a Collaboration to Inspire the Next Generation of Medical Imaging Professionals

October 1, 2026 | globenewswire.com

RadNet stock trades at EUR 7.68 after Q2 revenue growth

September 30, 2026 | ad-hoc-news.deA

RadNet (RDNT)

September 28, 2026 | es.investing.com

Bank of America Corp DE Invests $25.94 Million in RadNet, Inc. $RDNT

September 24, 2026 | marketbeat.com

RadNet stock falls 4.3 percent as shares trade below yearly high

September 22, 2026 | ad-hoc-news.deA

RadNet (NASDAQ:RDNT) Share Price Passes Above 200-Day Moving Average - Here's Why

September 22, 2026 | marketbeat.com

1 high-flying stock worth your attention and 2 we ignore

September 19, 2026 | msn.com

Jefferies Sticks to Its Buy Rating for Radnet (RDNT)

September 18, 2026 | theglobeandmail.com

FDA clears RadNet's foundation model-based chest X-ray AI tool

September 17, 2026 | radiologybusiness.comR

RadNet, Inc. (RDNT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

September 16, 2026 | seekingalpha.com

Hedgeye reiterates RadNet long idea

September 15, 2026 | seekingalpha.com

RadNet (RDNT) Stock May Be 23% Below Fair Value On Cash Flow

September 15, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

PGNY, HIMS, CHE, and RDNT Company Descriptions

Chemed NYSE:CHE

$499.14 +0.89 (+0.18%)

Closing price 10/9/2026 03:59 PM Eastern

Extended Trading

$492.57 -6.57 (-1.32%)

As of 10/9/2026 07:30 PM Eastern

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Hims & Hers Health NYSE:HIMS

$30.87 +2.81 (+10.00%)

Closing price 10/9/2026 03:59 PM Eastern

Extended Trading

$30.94 +0.08 (+0.25%)

As of 10/9/2026 07:59 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Progyny NASDAQ:PGNY

$27.93 +0.10 (+0.36%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$27.93 0.00 (0.00%)

As of 10/9/2026 07:30 PM Eastern

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

RadNet NASDAQ:RDNT

$70.91 +2.70 (+3.96%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$70.92 +0.01 (+0.01%)

As of 10/9/2026 07:30 PM Eastern

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PGNY, HIMS, CHE, and RDNT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PGNY, HIMS, CHE, and RDNT Earnings

Compare Dividends

Latest PGNY, HIMS, CHE, and RDNT Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PGNY, HIMS, CHE, and RDNT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

PGNY, HIMS, CHE, and RDNT Company Descriptions

Chemed NYSE:CHE

Hims & Hers Health NYSE:HIMS

Progyny NASDAQ:PGNY

RadNet NASDAQ:RDNT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools